Literature DB >> 22386056

HIV-2 viral protein X (Vpx) ubiquitination is dispensable for ubiquitin ligase interaction and effects on macrophage infection.

Anna McCulley1, Lee Ratner.   

Abstract

HIV-2 Vpx, a virus-associated accessory protein, is critical for infection of non-dividing myeloid cells. To understand the function of Vpx ubiquitination, interaction with an E3 ubiquitin ligase complex, and ability to overcome an inhibition of reverse transcription, we analyzed Vpx lysine mutants for their function and replication capability in macrophages. Both Wt Vpx and Vpx TA (lysine-less Vpx) localized to the cytoplasm and nucleus in HeLa cells. All HIV-2 Vpx lysine mutants were functional in virion packaging. However, ubiquitination was absent with Vpx TA and Vpx K84A mutants, indicating a lack of ubiquitin on positions K68 and K77. Mutants Vpx K68A and K77A were unable to infect macrophages due to impaired reverse transcription from loss of interaction with the ubiquitin substrate receptor, DCAF1. Even though Vpx K84A lacked ubiquitination, it bound DCAF1, and infected macrophages comparable to Wt Vpx. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22386056      PMCID: PMC3302174          DOI: 10.1016/j.virol.2012.02.002

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  55 in total

1.  The C-terminal proline-rich tail of human immunodeficiency virus type 2 Vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells.

Authors:  H A Pancio; N Vander Heyden; L Ratner
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.

Authors:  Andrew Mehle; Bettina Strack; Petronela Ancuta; Chengsheng Zhang; Mark McPike; Dana Gabuzda
Journal:  J Biol Chem       Date:  2003-12-13       Impact factor: 5.157

3.  Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain.

Authors:  S Mahalingam; B Van Tine; M L Santiago; F Gao; G M Shaw; B H Hahn
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells.

Authors:  B Müller; U Tessmer; U Schubert; H G Kräusslich
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  HIV type 2 Vpx interaction with Gag and incorporation into virus-like particles.

Authors:  L Jin; Y Zhou; L Ratner
Journal:  AIDS Res Hum Retroviruses       Date:  2001-01-20       Impact factor: 2.205

7.  Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses.

Authors:  C Depienne; P Roques; C Créminon; L Fritsch; R Casseron; D Dormont; C Dargemont; S Benichou
Journal:  Exp Cell Res       Date:  2000-11-01       Impact factor: 3.905

8.  Identification of the nuclear localization signal of human immunodeficiency virus type 2 Vpx.

Authors:  Michael Belshan; Lee Ratner
Journal:  Virology       Date:  2003-06-20       Impact factor: 3.616

9.  Vpx and Vpr proteins of HIV-2 up-regulate the viral infectivity by a distinct mechanism in lymphocytic cells.

Authors:  Fumiko Ueno; Hiroshi Shiota; Maki Miyaura; Akiko Yoshida; Akiko Sakurai; Junko Tatsuki; A Hajime Koyama; Hirofumi Akari; Akio Adachi; Mikako Fujita
Journal:  Microbes Infect       Date:  2003-04       Impact factor: 2.700

10.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.

Authors:  Kasia Hrecka; Caili Hao; Magda Gierszewska; Selene K Swanson; Malgorzata Kesik-Brodacka; Smita Srivastava; Laurence Florens; Michael P Washburn; Jacek Skowronski
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

View more
  3 in total

1.  Inhibitory Effects of HIV-2 Vpx on Replication of HIV-1.

Authors:  Mohamed Mahdi; Zsófia Szojka; János András Mótyán; József Tőzsér
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

2.  Incomplete Suppression of HIV-1 by SAMHD1 Permits Efficient Macrophage Infection.

Authors:  Timothy Plitnik; Mark E Sharkey; Bijan Mahboubi; Baek Kim; Mario Stevenson
Journal:  Pathog Immun       Date:  2018-12-06

3.  Role of poly-proline motif in HIV-2 Vpx expression.

Authors:  Ariko Miyake; Yasuyuki Miyazaki; Mikako Fujita; Masako Nomaguchi; Akio Adachi
Journal:  Front Microbiol       Date:  2014-01-28       Impact factor: 5.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.